Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Synthasome in December, 2004 for $69,960.0 USD from the U.S. Department of Defense. | SBIR | W911NF-05-C-0014 | Phase I | 69,960 | December 7, 2004 | |||||||
A SBIR Phase II contract was awarded to Synthasome for $1,662,660.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR051260-02 | Phase II | 1,662,660 | ||||||||
A SBIR Phase I contract was awarded to Synthasome for $323,003.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR060032-01 | Phase I | 323,003 | ||||||||
A SBIR Phase I contract was awarded to Synthasome for $298,262.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR051652-01 | Phase I | 298,262 | ||||||||
A SBIR Phase I contract was awarded to Synthasome for $261,074.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR056913-01 | Phase I | 261,074 | ||||||||
A SBIR Phase II contract was awarded to Synthasome for $1,615,392.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR060032-02 | Phase II | 1,615,392 | ||||||||
A SBIR Phase I contract was awarded to Synthasome for $222,759.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EB006538-01 | Phase I | 222,759 | ||||||||
A SBIR Phase I contract was awarded to Synthasome for $230,033.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR051260-01A1 | Phase I | 230,033 | ||||||||
A SBIR Phase II contract was awarded to Synthasome for $360,823.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44EB006538-02 | Phase II | 360,823 | ||||||||
A SBIR Phase II contract was awarded to Synthasome for $1,389,500.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44DE017308-02 | Phase II | 1,389,500 |